Candida auris : On Yılda Dünyaya Yayılmayı Başaran Fungal Patojen

GÜLMEZ KIVANÇ, DOLUNAY

doi:10.5578/flora.69056

Candida auris : On Yılda Dünyaya Yayılmayı Başaran Fungal Patojen

DOLUNAY GÜLMEZ KIVANÇ (Hacettepe Üniversitesi)

Flora İnfeksiyon Hastalıkları ve Klinik Mikrobiyoloji Dergisi

32 1

Yıl: 2019 Cilt: 24 Sayı: 4 Sayfa Aralığı: 263 - 271 Metin Dili: Türkçe DOI: 10.5578/flora.69056 İndeks Tarihi: 17-04-2020

Candida auris : On Yılda Dünyaya Yayılmayı Başaran Fungal Patojen

Öz:

Candida auris, son on yıl içinde dünyada yaygınlaşan ve sınırlanmasında güçlük çekilen nozokomiyal salgınlara neden olabilen bir fungal patojen olarak dikkati çekmiştir. Klinik mikrobiyoloji laboratuvarlarında tanımlanmasında güçlük yaşanması, sıklığının bildirilenden fazla olabileceğini düşündürmüştür. Düşkün hastalarda invaziv infeksiyonlara neden olabilmesi, yaygın yüksek flukonazol direnç oranları saptanması ve farklı antifungal sınıflarına karşı çoklu direnç gözlenebilmesi nedeniyle tedavi seçeneklerinin sınırlı olması ayrıca endişe uyandırmıştır. Ülkemize yakın coğrafi bölgelerin yanı sıra; 2019 yılında Yunanistan’da ve Avusturya’da Türk asıllı, Türkiye dışında yurtdışı seyahati bulunmayan bir hastada izole edilmiştir. Bu bulgular, ülkemizin bu sıra dışı patojenden uzun süre uzak kalamayacağını ve hazırlıklı olmamız gerektiğini düşündürmektedir.

Anahtar Kelime:

Konular: Biyoteknoloji ve Uygulamalı Mikrobiyoloji

Candida auris : The Fungal Pathogen That Managed to Spread Around the World in a Decade

Öz:

Candida auris attracts attention as a fungal pathogen that has become widespread worldwide in the last decade, which can cause uncontrollable nosocomial outbreaks. Difficulties of identification in clinical microbiology laboratories have suggested that the frequency may be more than reported. Since it may cause invasive infections in vulnerable patients, and the treatment options are limited due to detection of common high fluconazole resistance rates and observed resistance against different antifungal classes, it has raised additional concerns. As well as cases reported from geographical regions close to our country, in 2019 it was isolated in a patient in Greece and in another patient of Turkish origin in Austria, whose only international travel was to Turkey. These findings suggest that our country cannot be kept off this extraordinary pathogen for a long time and we should be prepared.

Anahtar Kelime:

Konular: Biyoteknoloji ve Uygulamalı Mikrobiyoloji

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık

1. Schelenz S, Hagen F, Rhodes JL, Abdolrasouli A, Chowdhary A, Hall A, et al. First hospital outbreak of the globally emerging Candida auris in a European hospital. Antimicrob Resist Infect Control 2016;5:35.
2. Ruiz-Gaitan A, Moret AM, Tasias-Pitarch M, Aleixandre-Lopez AI, Martinez-Morel H, Calabuig E, et al. An outbreak due to Candida auris with prolonged colonisation and candidaemia in a tertiary care European hospital. Mycoses 2018;61:498-505.
3. Calvo B, Melo AS, Perozo-Mena A, Hernandez M, Francisco EC, Hagen F, et al. First report of Candida auris in America: clinical and microbiological aspects of 18 episodes of candidemia. J Infect 2016;73:369-74.
4. Chowdhary A, Sharma C, Duggal S, Agarwal K, Prakash A, Singh PK, et al. New clonal strain of Candida auris, Delhi, India. Emerg Infect Dis 2013;19:1670-3.
5. Magobo RE, Corcoran C, Seetharam S, Govender NP. Candida auris-associated candidemia, South Africa. Emerg Infect Dis 2014;20:1250-1.
6. Emara M, Ahmad S, Khan Z, Joseph L, Al-Obaid I, Purohit P, et al. Candida auris candidemia in Kuwait, 2014. Emerg Infect Dis 2015;21:1091-2.
7. Borman AM, Szekely A, Johnson EM. Comparative pathogenicity of United Kingdom isolates of the emerging pathogen Candida auris and other key pathogenic Candida species. mSphere 2016;1.
8. Vallabhaneni S, Kallen A, Tsay S, Chow N, Welsh R, Kerins J, et al. Investigation of the first seven reported cases of Candida auris, a globally emerging invasive, multidrug-resistant fungus-United States, May 2013-August 2016. MMWR Morb Mortal Wkly Rep 2016;65:1234-7.
9. Ruiz Gaitan AC, Moret A, Lopez Hontangas JL, Molina JM, Aleixandre Lopez AI, Cabezas AH, et al. Nosocomial fungemia by Candida auris: first four reported cases in continental Europe. Rev Iberoam Micol 2017;34:23-7.
10. Chen Y, Zhao J, Han L, Qi L, Fan W, Liu J, et al. Emergency of fungemia cases caused by fluconazole-resistant Candida auris in Beijing, China. J Infect 2018;77:561-71.
11. Ong CW, Chen SC, Clark JE, Halliday CL, Kidd SE, Marriott DJ, et al. Diagnosis, management and prevention of Candida auris in hospitals: position statement of the Australasian Society for Infectious Diseases. Intern Med J 2019;49:1229-43.
12. Heath CH, Dyer JR, Pang S, Coombs GW, Gardam DJ. Candida auris sternal osteomyelitis in a man from Kenya Visiting Australia, 2015. Emerg Infect Dis 2019;25:192-4.
13. Centers for Disease Control and Prevention. Erişim Tarihi: 10.11.2019. Available from: https://www.cdc.gov/fungal/ candida-auris/index.html
14. European Centre for Disease Prevention and Control, Candida auris in healthcare settings–Europe–first update, 23 April 2018. 2018, ECDC: Stockholm.
15. Satoh K, Makimura K, Hasumi Y, Nishiyama Y, Uchida K, Yamaguchi H. Candida auris spp. nov., a novel ascomycetous yeast isolated from the external ear canal of an inpatient in a Japanese hospital. Microbiol Immunol 2009;53:41-4.
16. van Schalkwyk E, Mpembe RS, Thomas J, Shuping L, Ismail H, Lowman W, et al. Epidemiologic shift in candidemia driven by Candida auris, South Africa, 2016-2017(1). Emerg Infect Dis 2019;25:1698-707.
17. Adam RD, Revathi G, Okinda N, Fontaine M, Shah J, Kagotho E, et al. Analysis of Candida auris fungemia at a single facility in Kenya. Int J Infect Dis 2019;85:182-7.
18. Rudramurthy SM, Chakrabarti A, Paul RA, Sood P, Kaur H, Capoor MR, et al. Candida auris candidaemia in Indian ICUs: analysis of risk factors. J Antimicrob Chemother 2017;72:1794-801.
19. Mathur P, Hasan F, Singh PK, Malhotra R, Walia K, Chowdhary A. Five-year profile of candidaemia at an Indian trauma centre: high rates of Candida auris blood stream infections. Mycoses 2018;61:674-80.
20. Osei Sekyere J. Candida auris: a systematic review and meta-analysis of current updates on an emerging multidrug-resistant pathogen. Microbiologyopen 2018;7:e00578.
21. Bishop L, Cummins M, Guy R, Hoffman P, Jeffery K, Jeffery-Smith A, et al. Guidance for the laboratory investigation, management and infection prevention and control for cases of Candida auris. August 2017 v2.0. 2017, Public Health England: London.
22. Tan YE, Teo JQ, Rahman NBA, Ng OT, Kalisvar M, Tan AL, et al. Candida auris in Singapore: genomic epidemiology, antifungal drug resistance and identification using the updated 8.01 VITEK(R)2 system. Int J Antimicrob Agents 2019.
23. Pekard-Amenitsch S, Schriebl A, Posawetz W, Willinger B, Kolli B, Buzina W. Isolation of Candida auris from ear of otherwise healthy patient, Austria, 2018. Emerg Infect Dis 2018;24:1596-7.
24. Dewaele K, Lagrou K, Frans J, Hayette MP, Vernelen K. Hospital laboratory survey for identification of Candida auris in Belgium. J Fungi (Basel) 2019;5.
25. Kim MN, Shin JH, Sung H, Lee K, Kim EC, Ryoo N, et al. Candida haemulonii and closely related species at 5 university hospitals in Korea: identification, antifungal susceptibility, and clinical features. Clin Infect Dis 2009;48:e57-61.
26. Oh BJ, Shin JH, Kim MN, Sung H, Lee K, Joo MY, et al. Biofilm formation and genotyping of Candida haemulonii, Candida pseudohaemulonii, and a proposed new species (Candida auris) isolates from Korea. Med Mycol 2011;49:98-102.
27. Lee WG, Shin JH, Uh Y, Kang MG, Kim SH, Park KH, et al. First three reported cases of nosocomial fungemia caused by Candida auris. J Clin Microbiol 2011;49:3139-42.
28. Chowdhary A, Anil Kumar V, Sharma C, Prakash A, Agarwal K, Babu R, et al. Multidrug-resistant endemic clonal strain of Candida auris in India. Eur J Clin Microbiol Infect Dis 2014;33:919-26.
29. Tsay S, Welsh RM, Adams EH, Chow NA, Gade L, Berkow EL, et al. Notes from the field: ongoing transmission of Candida auris in health care facilities-United States, June 2016-May 2017. MMWR Morb Mortal Wkly Rep 2017;66:514-5.
30. Chow NA, Gade L, Tsay SV, Forsberg K, Greenko JA, Southwick KL, et al. Multiple introductions and subsequent transmission of multidrug-resistant Candida auris in the USA: a molecular epidemiological survey. Lancet Infect Dis 2018;18:1377-84.
31. Lockhart SR, Etienne KA, Vallabhaneni S, Farooqi J, Chowdhary A, Govender NP, et al. Simultaneous emergence of multidrug-resistant Candida auris on 3 continents confirmed by whole-genome sequencing and epidemiological analyses. Clin Infect Dis 2017;64:134-40.
32. Khan Z, Ahmad S, Al-Sweih N, Joseph L, Alfouzan W, Asadzadeh M. Increasing prevalence, molecular characterization and antifungal drug susceptibility of serial Candida auris isolates in Kuwait. PLoS One 2018;13:e0195743.
33. Riat A, Neofytos D, Coste A, Harbarth S, Bizzini A, Grandbastien B, et al. First case of Candida auris in Switzerland: discussion about preventive strategies. Swiss Med Wkly 2018;148:w14622.
34. Chowdhary A, Prakash A, Sharma C, Kordalewska M, Kumar A, Sarma S, et al. A multicentre study of antifungal susceptibility patterns among 350 Candida auris isolates (2009-17) in India: role of the ERG11 and FKS1 genes in azole and echinocandin resistance. J Antimicrob Chemother 2018;73:891-9.
35. Govender NP, Magobo RE, Mpembe R, Mhlanga M, Matlapeng P, Corcoran C, et al. Candida auris in South Africa, 2012-2016. Emerg Infect Dis 2018;24:2036-40.
36. Mohsin J, Hagen F, Al-Balushi ZAM, de Hoog GS, Chowdhary A, Meis JF, et al. The first cases of Candida auris candidaemia in Oman. Mycoses 2017;60:569-75.
37. Abdalhamid B, Almaghrabi R, Althawadi S, Omrani A. First report of Candida auris infections from Saudi Arabia. J Infect Public Health 2018;11:598-9.
38. Belkin A, Gazit Z, Keller N, Ben-Ami R, Wieder-Finesod A, Novikov A, et al. Candida auris infection leading to nosocomial transmission, Israel, 2017. Emerg Infect Dis 2018;24:801-4.
39. Alatoom A, Sartawi M, Lawlor K, AbdelWareth L, Thomsen J, Nusair A, et al. Persistent candidemia despite appropriate fungal therapy: first case of Candida auris from the United Arab Emirates. Int J Infect Dis 2018;70:36-7.
40. Stathi A, Loukou I, Kirikou H, Petrocheilou A, Moustaki M, Velegraki A, et al. Isolation of Candida auris from cystic fibrosis patient, Greece, April 2019. Euro Surveill 2019;24.
41. Ben-Ami R, Berman J, Novikov A, Bash E, Shachor-Meyouhas Y, Zakin S, et al. Multidrug-resistant Candida haemulonii and C. auris, Tel Aviv, Israel. Emerg Infect Dis 2017;23.
42. Escandon P, Chow NA, Caceres DH, Gade L, Berkow EL, Armstrong P, et al. Molecular epidemiology of Candida auris in Colombia reveals a highly related, countrywide colonization with regional patterns in amphotericin B resistance. Clin Infect Dis 2019;68:15-21.
43. Arauz AB, Caceres DH, Santiago E, Armstrong P, Arosemena S, Ramos C, et al. Isolation of Candida auris from 9 patients in Central America: importance of accurate diagnosis and susceptibility testing. Mycoses 2018;61:44-7.
44. Hamprecht A, Barber AE, Mellinghoff SC, Thelen P, Walther G, Yu Y, et al. Candida auris in Germany and previous exposure to foreign healthcare. Emerg Infect Dis 2019;25:1763-5.
45. Schwartz IS, Hammond GW. First reported case of multidrug-resistant Candida auris in Canada. Can Commun Dis Rep 2017;43:150-3.
46. Vogelzang EH, Weersink AJL, van Mansfeld R, Chow NA, Meis JF, van Dijk K. The first two cases of Candida auris in the Netherlands. J Fungi (Basel) 2019;5.
47. Dewaele K, Frans J, Smismans A, Ho E, Tollens T, Lagrou K. First case of Candida auris infection in Belgium in a surgical patient from Kuwait. Acta Clin Belg 2018:1-8.
48. Morales-Lopez SE, Parra-Giraldo CM, Ceballos-Garzon A, Martinez HP, Rodriguez GJ, Alvarez-Moreno CA, et al. Invasive infections with multidrug-resistant yeast Candida auris, Colombia. Emerg Infect Dis 2017;23:162-4.
49. Escandon P, Caceres DH, Espinosa-Bode A, Rivera S, Armstrong P, Vallabhaneni S, et al. Notes from the field: surveillance for Candida auris-Colombia, September 2016-May 2017. MMWR Morb Mortal Wkly Rep 2018;67:459-60.
50. Mizusawa M, Miller H, Green R, Lee R, Durante M, Perkins R, et al. Can multidrug-resistant Candida auris be reliably identified in clinical microbiology laboratories? J Clin Microbiol 2017;55:638-40.
51. Bajpai V, Govindaswamy A, Sagar S, Kumar S, Garg P, Xess I, et al. Multidrug-resistant Candida auris fungemia in critical care units: experience from a tertiary care Hospital in India. Microb Drug Resist 2019.
52. Kathuria S, Singh PK, Sharma C, Prakash A, Masih A, Kumar A, et al. Multidrug-resistant Candida auris misidentified as Candida haemulonii: characterization by matrix-assisted laser desorption ionization-time of flight mass spectrometry and DNA sequencing and its antifungal susceptibility profile variability by Vitek 2, CLSI broth microdilution, and Etest method. J Clin Microbiol 2015;53:1823-30.
53. Al-Siyabi T, Al Busaidi I, Balkhair A, Al-Muharrmi Z, Al-Salti M, Al’Adawi B. First report of Candida auris in Oman: clinical and microbiological description of five candidemia cases. J Infect 2017;75:373-6.
54. Azar MM, Turbett SE, Fishman JA, Pierce VM. Donor-derived transmission of Candida auris during lung transplantation. Clin Infect Dis 2017;65:1040-2.
55. Parra-Giraldo CM, Valderrama SL, Cortes-Fraile G, Garzon JR, Ariza BE, Morio F, et al. First report of sporadic cases of Candida auris in Colombia. Int J Infect Dis 2018;69:63-7.
56. Wang X, Bing J, Zheng Q, Zhang F, Liu J, Yue H, et al. The first isolate of Candida auris in China: clinical and biological aspects. Emerg Microbes Infect 2018;7:93.
57. Iguchi S, Mizushima R, Kamada K, Itakura Y, Yoshida A, Uzawa Y, et al. The second Candida auris isolate from aural discharge in Japan. Jpn J Infect Dis 2018;71:174-5.
58. Iguchi S, Itakura Y, Yoshida A, Kamada K, Mizushima R, Arai Y, et al. Candida auris: a pathogen difficult to identify, treat, and eradicate and its characteristics in Japanese strains. J Infect Chemother 2019;25:743-9.
59. Jung J, Kim MJ, Kim JY, Lee JY, Kwak SH, Hong MJ, et al. Candida auris colonization or infection of the ear: a single-center study in South Korea from 2016 to 2018. Med Mycol 2019.
60. Choi HI, An J, Hwang JJ, Moon SY, Son JS. Otomastoiditis caused by Candida auris: case report and literature review. Mycoses 2017;60:488-92.
61. Eyre DW, Sheppard AE, Madder H, Moir I, Moroney R, Quan TP, et al. A Candida auris outbreak and its control in an intensive care setting. N Engl J Med 2018;379:1322-31.
62. Armstrong PA, Rivera SM, Escandon P, Caceres DH, Chow N, Stuckey MJ, et al. Hospital-associated multicenter outbreak of emerging fungus Candida auris, Colombia, 2016. Emerg Infect Dis 2019;25.
63. Barantsevich NE, Orlova OE, Shlyakhto EV, Johnson EM, Woodford N, Lass-Floerl C, et al. Emergence of Candida auris in Russia. J Hosp Infect 2019;102:445-8.
64. Khan Z, Ahmad S, Benwan K, Purohit P, Al-Obaid I, Bafna R, et al. Invasive Candida auris infections in Kuwait hospitals: epidemiology, antifungal treatment and outcome. Infection 2018;46:641-50.
65. Tian S, Rong C, Nian H, Li F, Chu Y, Cheng S, et al. First cases and risk factors of super yeast Candida auris infection or colonization from Shenyang, China. Emerg Microbes Infect 2018;7:128.
66. CLSI. Performance Standards for Antifungal Susceptibility Testing of Yeasts. CLSI Supplement M60. 1th ed. Wayne, PA: Clinical and Laboratory Standards Institute, 2017.
67. EUCAST. Erişim Tarihi: 10.11.2019. Available from: http:// www.eucast.org/fileadmin/src/media/PDFs/EUCAST_files/AFST/Clinical_breakpoints/Antifungal_breakpoints_v_9.0_180212.pdf
68. Arendrup MC, Prakash A, Meletiadis J, Sharma C, Chowdhary A. Comparison of EUCAST and CLSI reference microdilution MICs of eight antifungal compounds for Candida auris and associated tentative epidemiological cutoff values. Antimicrob Agents Chemother 2017;61.
69. Khillan V, Rathore N, Kathuria S, Chowdhary A. A rare case of breakthrough fungal pericarditis due to fluconazole-resistant Candida auris in a patient with chronic liver disease. JMM Case Reports 2014;1:1-5.
70. Biswal M, Rudramurthy SM, Jain N, Shamanth AS, Sharma D, Jain K, et al. Controlling a possible outbreak of Candida auris infection: lessons learnt from multiple interventions. J Hosp Infect 2017;97:363-70.
71. Cadnum JL, Shaikh AA, Piedrahita CT, Sankar T, Jencson AL, Larkin EL, et al. Effectiveness of disinfectants against Candida auris and other Candida species. Infect Control Hosp Epidemiol 2017;38:1240-3.
72. Kean R, Sherry L, Townsend E, McKloud E, Short B, Akinbobola A, et al. Surface disinfection challenges for Candida auris: an in-vitro study. J Hosp Infect 2018;98:433-6.
73. Kean R, McKloud E, Townsend EM, Sherry L, Delaney C, Jones BL, et al. The comparative efficacy of antiseptics against Candida auris biofilms. Int J Antimicrob Agents 2018;52:673-7.

APA	GÜLMEZ KIVANÇ D (2019). Candida auris : On Yılda Dünyaya Yayılmayı Başaran Fungal Patojen. , 263 - 271. 10.5578/flora.69056
Chicago	GÜLMEZ KIVANÇ DOLUNAY Candida auris : On Yılda Dünyaya Yayılmayı Başaran Fungal Patojen. (2019): 263 - 271. 10.5578/flora.69056
MLA	GÜLMEZ KIVANÇ DOLUNAY Candida auris : On Yılda Dünyaya Yayılmayı Başaran Fungal Patojen. , 2019, ss.263 - 271. 10.5578/flora.69056
AMA	GÜLMEZ KIVANÇ D Candida auris : On Yılda Dünyaya Yayılmayı Başaran Fungal Patojen. . 2019; 263 - 271. 10.5578/flora.69056
Vancouver	GÜLMEZ KIVANÇ D Candida auris : On Yılda Dünyaya Yayılmayı Başaran Fungal Patojen. . 2019; 263 - 271. 10.5578/flora.69056
IEEE	GÜLMEZ KIVANÇ D "Candida auris : On Yılda Dünyaya Yayılmayı Başaran Fungal Patojen." , ss.263 - 271, 2019. 10.5578/flora.69056
ISNAD	GÜLMEZ KIVANÇ, DOLUNAY. "Candida auris : On Yılda Dünyaya Yayılmayı Başaran Fungal Patojen". (2019), 263-271. https://doi.org/10.5578/flora.69056

APA	GÜLMEZ KIVANÇ D (2019). Candida auris : On Yılda Dünyaya Yayılmayı Başaran Fungal Patojen. Flora İnfeksiyon Hastalıkları ve Klinik Mikrobiyoloji Dergisi, 24(4), 263 - 271. 10.5578/flora.69056
Chicago	GÜLMEZ KIVANÇ DOLUNAY Candida auris : On Yılda Dünyaya Yayılmayı Başaran Fungal Patojen. Flora İnfeksiyon Hastalıkları ve Klinik Mikrobiyoloji Dergisi 24, no.4 (2019): 263 - 271. 10.5578/flora.69056
MLA	GÜLMEZ KIVANÇ DOLUNAY Candida auris : On Yılda Dünyaya Yayılmayı Başaran Fungal Patojen. Flora İnfeksiyon Hastalıkları ve Klinik Mikrobiyoloji Dergisi, vol.24, no.4, 2019, ss.263 - 271. 10.5578/flora.69056
AMA	GÜLMEZ KIVANÇ D Candida auris : On Yılda Dünyaya Yayılmayı Başaran Fungal Patojen. Flora İnfeksiyon Hastalıkları ve Klinik Mikrobiyoloji Dergisi. 2019; 24(4): 263 - 271. 10.5578/flora.69056
Vancouver	GÜLMEZ KIVANÇ D Candida auris : On Yılda Dünyaya Yayılmayı Başaran Fungal Patojen. Flora İnfeksiyon Hastalıkları ve Klinik Mikrobiyoloji Dergisi. 2019; 24(4): 263 - 271. 10.5578/flora.69056
IEEE	GÜLMEZ KIVANÇ D "Candida auris : On Yılda Dünyaya Yayılmayı Başaran Fungal Patojen." Flora İnfeksiyon Hastalıkları ve Klinik Mikrobiyoloji Dergisi, 24, ss.263 - 271, 2019. 10.5578/flora.69056
ISNAD	GÜLMEZ KIVANÇ, DOLUNAY. "Candida auris : On Yılda Dünyaya Yayılmayı Başaran Fungal Patojen". Flora İnfeksiyon Hastalıkları ve Klinik Mikrobiyoloji Dergisi 24/4 (2019), 263-271. https://doi.org/10.5578/flora.69056